We are live on ! Find out more
ZOM

Zomedica Corp.

Delisted

ZOM was delisted on the 4th of March, 2025.

99 hedge funds and large institutions have $12.4M invested in Zomedica Corp. in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

8% more funds holding

Funds holding: 9299 (+7)

30% less capital invested

Capital invested by funds: $17.8M → $12.4M (-$5.37M)

38% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 21

Holders
99
Holders Change
+7
Holders Change %
+7.61%
% of All Funds
1.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
13
Reduced
21
Closed
9
Calls
Puts
Net Calls
Net Calls Change

ZOM Hedge Fund Activity: Q1 2024 in Review

99 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q1 2024, worth a combined $12.4M — down 30% from $17.8M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ZOM positions and 9 closed out — a net gain of 7 holders — while 13 added to existing stakes and 21 trimmed.

The largest buyer was Atom Investors, opening a new position worth an estimated $168K. The largest seller was ProShare Advisors, exiting entirely with an estimated $515K sold.

  • 99 institutional investors held Zomedica Corp. (ZOM) as of Q1 2024, up from 92 in Q4 2023.
  • Funds reported $12.4M of Zomedica Corp. stock for Q1 2024, down 30% quarter-over-quarter.
  • 16 funds opened new Zomedica Corp. positions in Q1 2024 and 9 closed out, a net change of +7 holders.
  • The largest Zomedica Corp. buyer in Q1 2024 was Atom Investors, an estimated $168K added.
  • The largest Zomedica Corp. seller in Q1 2024 was ProShare Advisors, an estimated $515K sold.

Based on aggregated 13F filings for Q1 2024.